Winship receives $11 million grant from the National Cancer Institute to improve immunotherapy for lung cancer

Winship has been awarded a P01 program project grant from the National Cancer Institute to support research aimed at improving the effectiveness of immunotherapy for lung cancer in patients with a mutation of the LKB1 gene, a group for whom the present immunotherapy options do not provide robust benefit. The award will provide nearly $11 million over five years to a team of Winship researchers led by Haian Fu, PhD (left), and Suresh Ramalingam, MD (right).

Clinical trial led by Winship shows promise for HNSCC patients

Ninety-one percent of the participants with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) experienced clinical benefit in a phase 2 trial of cabozantinib in combination with pembrolizumab. Winship oncologist Nabil F. Saba, MD, who led the study, recently presented the results during an oral abstract session at the annual meeting of the American Society of Clinical Oncology.

Palmer joins Winship as VP of cancer clinical administration and strategy

Stacy L. Palmer, MBA, joins Winship on June 6 as the new vice president of cancer clinical administration and strategy. Palmer, who served as associate dean for strategic planning and chief of staff at Duke University Medical School, brings to the role more than 25 years of experience in health care delivery systems, academic medicine, life sciences and consulting.

Four stories of cancer survivorship

Held annually on the first Sunday of June, National Cancer Survivors Day is a celebration of survivors of cancer–more than 16.9 million in America–and an occasion to draw attention to the resources and research for improving cancer survivorship. Meet Edward, Maryann, Johan and Jennifer, who were treated for cancer at Winship, and hear their inspiring stories.

Winship Oncology Nursing Symposium set for June 11

The annual Winship Oncology Nursing Symposium, “Charting Your Path as an Oncology Nurse: Tales from the Trenches,” will be held on Saturday, June 11. The virtual continuing education program, which offers up to 20 contact hours, is complimentary for Emory employees and discounted for participants from other institutions.

CDC releases draft cancer cluster guidelines for public comment

The Centers for Disease Control and Prevention has released a draft of its Guidelines for Examining Unusual Patterns of Cancer and Environmental Concerns for public comment. Comments are open through the Federal Register until July 25.

Call for proposals: Gabrielle’s Angel grants

Gabrielle’s Angel Foundation for Cancer Research is committed to funding innovative, translational proposals and to supporting promising independent early‐career investigators. Projects will be funded for a three‐year period at $75,000 per year. Letters of intent are due June 17.

Learn More

Below are four selected Winship publications out of 68 published over the past week:

Siefker-Radtke AO, Cho DC, Diab A, Sznol M, Bilen MA, Balar AV, Grignani G, Puente E, Tang L, Chien D, Hoch U, Choudhury A, Yu D, Currie SL, Tagliaferri MA, Zalevsky J, Hurwitz ME, Tannir NM. Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02. European Urology. 2022; PubMed PMID: 35643589.

View in PubMed

Ning L, Shim J, Tomov ML, Liu R, Mehta R, Mingee A, Hwang B, Jin L, Mantalaris A, Xu C, Mahmoudi M, Goldsmith KC, Serpooshan V. A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior. Advanced Science. 2022; e2200244. PubMed PMID: 35644929.

View in PubMed

Harris HR, Guertin KA, Camacho TF, Johnson CE, Wu AH, Moorman PG, Myers E, Bethea TN, Bandera EV, Joslin CE, Ochs-Balcom HM, Peres LC, Rosenow WT, Setiawan VW, Beeghly-Fadiel A, Dempsey LF, Rosenberg L, Schildkraut JM. Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry (OCWAA) consortium. International Journal of Cancer. 2022; PubMed PMID: 35633315.

View in PubMed

Cherven B, Lewis RW, Pruett M, Meacham L, Klosky JL. Interest in fertility status assessment among young adult survivors of childhood cancer. Cancer Medicine. 2022; PubMed PMID: 35651304.

View in PubMed